Three things to know:
1. The system is designed for treating traumatic and fragility fractures of the humerus, radius and ulna in skeletally mature patients.
2. The IlluminOss system’s minimally invasive technology produces patient-specific intramedullary implants for fracture fixation. The device is a light-curable polymer with an expandable balloon catheter within it used to achieve bone stabilization. The procedure uses a small percutaneous surgical approach to provide patient-specific orthopedic stabilization,
3. The IlluminOss system received initial FDA clearance in December 2017 for fractures associated with metastatic bone. The minimally invasive orthopedic fracture repair company received FDA clearance for traumatic and fragility fractures in August 2018.
More articles on devices:
21 spine devices receive FDA 510(k) clearance in January
SeaSpine expands board of directors – 4 insights
Medtronic CEO Omar Ishrak projects future spine business growth: 4 key quotes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
